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ABSTRACT In the past ten years, diabetes prevalence has increased rapidly in low- and middle-income countries due to
lifestyle changes. This increased number of diabetic patients leads to the escalation of recombinant insulin demand, which
is creating a large global insulin market. Pichia pastoris has appeared as an alternative host to produce recombinant proteins.
It has excellent qualifications as an expression host for large-scale production of recombinant proteins for therapeutic use. In
this study, we attempted to express the insulin precursor (IP) in P. pastoris. We used a synthetic IP-encoding gene constructed
in frame with the truncated α-factor secretory signal and a short C-peptide (DGK) linked A- and B-chain of human insulin in
a pD902 expression vector. Several zeocin resistant clones were successfully obtained and verified with PCR using AOX1
specific primers for the integration of the expression cassette into the P. pastoris genome and for the identification ofMut phe-
notypes. The secretion of IP by the Pichia pastoris clone in the culture supernatant was confirmed using SDS-PAGE, where a
single band of the secreted IP with amolecular mass above 6.5 kDawas found.
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1. Introduction
Insulin is a naturally occurring polypeptide hormone pro-
duced by β-cells of the pancreas, and plays an essential
role in regulating blood glucose levels as part of the hu-
man metabolism (Kjeldsen et al. 2002). Consequently, it
also serves as the most important drug in the treatment all
types of insulin-lacking diabetic patients, to reduce blood
sugar. Insulin demand continues to increase every year,
together with the increasing number of diabetic patients
around the world. TheWorld Health Organization (WHO)
estimated that around 422 million people suffered from di-
abetes mellitus in 2014 (WHO 2016), and this number is
predicted to increase to 642 million by 2040 (Ogurtsova
et al. 2017). A prolonged hyperglycemic condition caused
by diabetes often leads to the multiple organ damage and
failure. As such, diabetes has presently become one of
the leading causes of death globally. It caused 1.5 million
deaths in 2012 (WHO 2016).
To meet insulin demand, large-scale recombinant hu-
man insulin production is currently employing two ma-
jor systems which involve Escherichia coli and Saccha-
romyces cerevisiae as hosts (Baeshen et al. 2014). With
the E. coli as an expression host, insulin precursor (IP) is
expressed in the form of inclusion bodies that need solu-
bilization and refolding procedures (Nilsson et al. 1996).
The other system uses yeast expression hosts (mainly S.
cerevisiae) where the soluble IP is secreted into culture su-
pernatant (Thim et al. 1986; Kjeldsen 2000). Though half
of the world insulin supply is produced using the S. cere-
visiae system (Meehl and Stadheim 2014), several alter-
native yeast hosts are available for recombinant proteins
expression (Porro et al. 2005). The methylotrophic yeast
Pichia pastoris is one of the promising yeast hosts for re-
combinant proteins expression. It has several excellent
characteristics such as its ability to grow to a very high
cell density and to express a high amount of recombinant
proteins under the control of strong and tightly regulated
promoters (Ahmad et al. 2014). It also has low levels of se-
creted native proteins which simplify the purification of se-
creted recombinant proteins (Cregg et al. 1993). There are
several reports investigating the secretory expression of IP
in P. pastoris that have proved that P. pastoris is applica-
ble for IP production (Kjeldsen et al. 1999; Wang et al.
2001; Xie et al. 2008; Gurramkonda et al. 2009; Baeshen
et al. 2016; Polez et al. 2016).
The human insulin, which is characterized to have a
molecular weight of 5.8 kDa, is composed of 51 amino
acids. Insulin synthesis begins with the formation of a
single polypeptide, named preproinsulin, in the pancreatic
β-cells. The preproinsulin has a 24-residue signal pep-
tide which has a role to leads the translocation of the im-
mature polypeptide into the endoplasmic reticulum (ER).
Proinsulin is then formed in the ER after removal of the
signal peptide and folded into exact conformation with
three disulphide bonds. Cellular endopeptidases cleave
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34 amino acids, termed as C-peptide, from the folded in-
sulin to form mature insulin. Thus, the mature insulin
consists of two chains, A- and B-chain containing 21 and
30 amino acids, respectively. Two interchain disulphide
bonds linked the polypeptide A- and B-chain. Addition-
ally, the A-chain has an intrachain disulphide bond (Fu
et al. 2013; Baeshen et al. 2014).
The secretory expression of various heterologous pro-
teins in S. cerevisiae and P. pastoris utilized S. cere-
visiae mating factor α (α-factor) prepro-leader (Kjeldsen
et al. 1999). It consists of a 19-residue signal (pre) se-
quence followed by a 67-residue pro-sequence containing
three consensus N-linked glycosylation sites and a diba-
sic Kex2 endoprotease processing site (Kurjan and Her-
skowitz 1982). Since the secretion of proinsulin expressed
in S. cerevisiae is inefficient, a cDNA encoding proinsulin-
like molecule (with deletion of Thr at B30) fused with
the S. cerevisiae α-factor and followed by replacement
of the human proinsulin C-peptide with a short C-peptide
such as Ala-Ala-Lys (AAK) results in the efficient secre-
tion of proinsulin-like molecules to the culture supernatant
(Kjeldsen 2000). Several studies employed full-length α-
factor leader sequence and short C-peptide (AAK) for in-
sulin secretory expression in P. pastoris (Kjeldsen et al.
1999; Xie et al. 2008; Gurramkonda et al. 2009; Polez
et al. 2016), which resulted up to 3.6 g/L secreted IP. Other
study reported strain, which employed short C-peptide
Asp-Gly-Lys (DGK), expressed a higher yield of IP rela-
tive to the strain employed C-peptide AAK (Kjeldsen et al.
2012 Mar 6). On the other hand, Lin-Cereghino et al.
(2013) have determined the influence of deletions and sub-
stitutions of the prepro region of the α-mating factor secre-
tion signal sequence by site-directed mutagenesis. They
reported that the deletion of part of the second alpha he-
lix (MATα: ∆30-43) and removal of the entire last helix,
which included some N-terminal residues (MATα: ∆57-
70), increased secretion of a reporter protein horseradish
peroxidase (HRP). In this study, we employed truncated
α-factor leader sequence consisting of 57 amino acids se-
cretion signal, derived from S. cerevisiae α-factor with
deleted region at the second alpha helix (MATα: ∆30-43)
and the entire last helix (MATα: ∆57-70) plus a Kex (KR)
cleavage site and a short C-peptide (DGK) for insulin pre-
cursor secretory expression in P. pastoris.
2. Materials andmethods
2.1. Cloning of IP expression vector in E. coli
A Pichia integrative vector pD902-IP harbouring IP ex-
pression cassette consisting of a truncated α-factor secre-
tion signal sequence, spacer peptide, synthetic IP encoding
gene codon-optimized for expression in P. pastoris, and a
short linker connecting insulin B-chain and A-chain, was
provided by ATUM. For subsequent transformation into
P. pastoris X33 (Invitrogen, Carlsbad, CA), the pD902-IP
plasmid was firstly cloned in E. coli TOP10 by CaCl2-heat
shock method as previously described by Sambrook and
Russel (2001). The E. coli transformants were selected
in LB plate supplemented with zeocin™ (100 μg/mL).
Zeocin™-resistant transformants were inoculated into 2
mL LB medium with 100 μg/mL Zeocin™ and cultured
overnight at 37°C with shaking. Plasmid DNA was iso-
lated by QIAprep SpinMiniprep Kit (Qiagen, Hilden, Ger-
many) following the manufacturer’s instruction. Plasmid
confirmation was done by restriction analysis using SacI
restriction enzyme.
2.2. Transformation of pD902-IP intoP. pastoris
The pD902-PI construct was transformed into P. pastoris
X33 strain by electroporation followed the EasySelect™
Pichia Expression Kit manual (Invitrogen 2010). About
5–10 μg of pD902-PI plasmid DNA was linearized with
SacI in order to obtain efficient integration of the recom-
binant construct into Pichia genome. SacI enzyme cuts
one time in the 5´ AOX1 region to linearize the pD902-
PI plasmid. A small aliquot of the plasmid digestion mix
was run by agarose gel electrophoresis to check complete
linearization of the plasmid. The linearized plasmid was
then purified by QIAquick PCR Purification Kit (Qiagen,
Hilden, Germany). On the other hand, P. pastoris cells
were prepared for electroporation. An overnight culture
(0.01–0.05 mL) of P. pastoris X33 strain was inoculated
into 50 mL of fresh YPD medium (1% (w/v) yeast extract,
2% (w/v) peptone, 2% (w/v) glucose) in 250 mL flask and
allowed to grow overnight at 30°C to an OD600 = 1.3–1.5.
The cells were harvested by centrifugation 1,500 × g for
5 min at 4°C and the cell pellet was washed twice with
ice-cold sterile water 50 and 25 mL, respectively. Then
the cell pellet was washed once with 2 mL of ice-cold 1
M sorbitol. Cells were centrifuged at 1,500 × g for 5 min
at 4°C and the cell pellet was resuspended in 1 mL of ice-
cold 1 M sorbitol, cells were kept on ice. An 80 μL of the
cells was mixed with∼1 μg of linearized plasmid DNA in
10 μL sterile water. The mixture was then transferred to an
ice-cold 0.2 cm electroporation cuvette. The cuvette with
the cells was incubated on ice for 5 min and pulsed follow-
ing the manufacturer’s instructions for P. pastoris (Gene
Pulser XcellTM Electroporation Systems, Bio-Rad). Im-
mediately, 1 mL of ice-cold 1 M sorbitol was added to the
cuvette. The cuvette contents were transferred to a ster-
ile 15 mL tube and incubated at 30°C without shaking for
2 h. To obtain more transformant colonies, 1 mL YPD
medium was added to each tube and shaken 200 rpm for
1 h. Cell suspension in 50–100 μL YPD was plated on
YPDS plates (1% (w/v) yeast extract, 2% (w/v) peptone,
2% (w/v) glucose, 1% (w/v) sorbitol, 2% (w/v) agar) con-
taining 100 μg/mL zeocin and incubated at 30°C for 3–10
d until colonies form.
2.3. Selecting multicopy clones and identification of
Mut phenotypes
Multicopy clones were identified by selecting the P. pas-
toris transformants on YPD plates (1% (w/v) yeast ex-
tract, 2% (w/v) peptone, 2% (w/v) glucose, 2% (w/v)
agar), containing progressively increasing concentrations
of zeocin (100–2000 µg/mL). PCR analysis was done to
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confirm the integration of linearized vector pD902-PI into
P. pastoris genome and to define Mut phenotype using
an AOX1 specific primer set consisted of AOX1F (5’-
GACTGGTTCCAATTGACAAGC-3’) and AOX1R (5’-
GCAAATGGCATTCTGACATCC-3’). The primers are
listed in the EasySelect™ Pichia Expression Kit manual
(Invitrogen 2010). Genomic DNAs of 19 P. pastoris trans-
formants were isolated using YeaStar Genomic DNA Kit
(Zymo Research Corp., Irvine, USA) following the manu-
facturer’s instructions. The isolated genomic DNAs were
then used as the template for PCR amplification using
Dream Taq DNA polymerase (Thermo Fisher Scientific,
Lithuania). PCR amplification with AOX1 primer set was
carried out in a 25 μL mixture (total volume) containing
∼400 ng of P. pastoris genomic DNA, 2.5 µL 10-fold re-
action Dream Taq buffer, 2 mM dNTPs, 0.5 µM of each
primer, and 1.25 U Dream Taq DNA polymerase under
the following PCR conditions: 95°C for 3 min; then 35
cycles at 95°C for 30 s, 55°C for 30 s, and 72°C for 1 min;
followed by last cycle at 72°C for 5 min.
2.4. Secreted expression of IP protein
A single colony of P. pastoris recombinant strain was inoc-
ulated into 10mLBMGYmedium (1% (w/v) yeast extract,
2% (w/v) peptone, 100 mM potassium phosphate pH 6.0,
1.34% (w/v) YNB, 4 x 10-5% (w/v) biotin, 1% (v/v) glyc-
erol) in a 250 mL flask and grown at 30°C in a shaking
incubator (250 rpm) until the culture reached an OD600
= 2–6 (approximately 16–18 h). The cells were harvested
by centrifuging at 1,500-3,000× g for 5 min at room tem-
perature. Cell pellet was resuspended to an OD600 of 1.0
in BMMYmedium (1% (w/v) yeast extract, 2% (w/v) pep-
tone, 100 mM potassium phosphate pH 6.0, 1.34% (w/v)
YNB, 4 × 10-5% (w/v) biotin, 0.5% (v/v) methanol) to
induce expression (approximately 10 mL). Culture was
placed in a 250 mL flask. A 100% methanol was added to
a final concentration of 0.5%methanol every 24 h to main-
tain induction. After 3 d methanol induction, supernatant
was transferred to a separate tube and stored at −20°C until
ready to assay.
2.5. Protein analysis
The supernatant of culture broth samples was concentrated
10 times using Centrifugal Filter Units (Merck Millipore,
Germany) and analyzed by denaturing 10% polyacrylam-
ide gel electrophoresis using the Tricine buffer system
(Haider et al. 2012). Samples (20 μL) were mixed with an
equal volume of Tricine sample buffer, mixed and boiled
for 15 min. Samples were loaded on to the gel (20 μL
per lane) and electrophoresed, the separated polypeptides
were visualized using Blue Lightning Stain (Vivantis Tech-
nologies Sdn. Bhd., Malaysia). IP protein concentra-
tion was analysed by performing Tris/Tricine/Urea SDS-
PAGE which employs 6 M urea in 15% polyacrylamide
to resolve low molecular weight protein band (Okita
et al. 2017). Protein concentration in Tris/Tricine/Urea
SDS-PAGE was determined using imageJ by applying
lysozyme as standard ranging from 0.01–1.25 mg/mL.
3. Results and discussion
3.1. Cloning of synthetic IP constructed in the expres-
sion vector pD902 in E. coli
In this study, an IP cassette for human IP expression was
constructed in the Pichia integrative vector pD902 under
the control of a strong and inducible AOX1 promoter. The
IP cassette consisted of S. cerevisiae truncated α-factor
secretory signal located at 5’ terminus of the IP expres-
sion cassette which contains Kex2 cleavage site (LEKR)
at its carboxy-terminal part, followed by a spacer pep-
tide (EEAEAEAEPK) for more efficient Kex2 process-
ing and secretion (Kjeldsen et al. 1999), followed by 29
amino acid residues of insulin B-chain, a short connect-
ing linker (DGK), and finally 21 amino acid residues of




FIGURE 1 (a) The IP expression cassette for human insulin secre-
tory expression inP. pastoris. Theblack triangle denotesKex2 cleav-
age site; (b) Map of the pD902 yeast integrative vector encoding
IP (pD902-IP). The IP encoding gene is expressed under the control
of strong inducible promoter AOX1; (c) Amino acid sequence align-
ment of the full-length and truncated α-factor.
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peptide (prepro-leader peptide) commonly used in S. cere-
visiae and P. pastoris for secreted expression of a heterol-
ogous protein. However, P. pastoris is often unable to
secrete some proteins even though it has a proper secre-
tion leader. The α-factor divided into two parts: a pre-
and pro-peptide (Lin-Cereghino et al. 2013). Pre-peptide
is thought to build an alpha helix which can bind to the sig-
nal recognition particle required for entry into ER (Stern
et al. 2007). The pre-peptide deletion caused no activity
of HRP reporter protein. Whereas, the pro-peptide has an
important role in the secretion efficiency because of dele-
tion of some parts of it such as MAα: ∆30-43 and MATα:
∆57-70 increased secretion about 20-30 and 50%, respec-
tively (Lin-Cereghino et al. 2013). Therefore in this study,
we used truncated α-factor with the deleted region at the
second alpha helix (MATα: ∆30–43) and the entire last he-
lix (MATα: ∆57–70) to obtain more efficient secretion of
the IP (Figure 1c). Spacer peptide (EEAEAEAEPK) was
inserted between α factor and insulin B-chain to increase
the fermentation yield of IP in P. pastoris as previously re-
ported by Kjeldsen et al. (1999) that the addition of spacer
peptide EEAEAEAEPK in the IP fusion protein enhanced
yield up to 167%.
The expression cassette of IP was constructed in the
pD902 plasmid named pD902-IP (Figure 1b). The pD902-
IP was then cloned in E. coli TOP10 and the E. coli clone
harbouring pD902-IP was confirmed by digestion using
SacI restriction enzyme which resulted in one fragment
size of ∼3921 bp (Figure 2).
3.2. Transformation of P. pastoris and identification of
Mut phenotypes
P. pastoris is a methylotrophic yeast which is able to me-
tabolize methanol as sole carbon source through methanol
utilization (Mut) pathway. Alcohol oxidase (AOX) en-
zymes involved in the first step of methanol metabolism.
They are encoded by two genes in P. pastoris, AOX1 and
AOX2 genes (Juturu and Wu 2018). AOX1 gene expres-
sion is regulated by AOX1 strong promoter which was
used in this study to drive the heterologous expression of
IP protein in P. pastoris. In the transformation step, the
SacI linearized pD902-IP was introduced into P. pastoris
FIGURE 2 Agarose electrophoresis of pD902-IP digestion by SacI.
M = marker 1 kb plus DNA ladder; 1 = pD902-IP; 2 = pD902-IP di-
gested bySacI.
X33 electrocompetent cells to facilitate single crossover
recombination at the AOX1 locus. Transformants were se-
lected in YPDS medium supplemented with zeocin (100
μg/mL). After 3 d incubation, 19 colonies transformants
were formed on the sample plate of P. pastoris competent
cells introduced by pD902-IP, whereas no colonies were
grown on the negative control plate (Figure 3).
In order to select putative multicopy recombinant
strains, the transformants were further cultured in the YPD
agar supplemented with increasing zeocin concentrations
(100–2000 µg/mL). All 19 of the transformants were able
to recover up to the highest zeocin concentration (2000
µg/mL) (Figure 4). This result may reveal that the transfor-
mants can be identified as multicopy clones (>2 copy inte-
grants). As the clone survival at the zeocin concentration
up to 500 µg/mL indicates a copy number of 2 (Vassileva
et al. 2001). We can expect from amulticopy transformant
a higher expression level of IP since the expression level of
IP in P. pastoris/pPIC9K system could be increased with
the increasing of gene dosage (Wang et al. 2001). How-
ever, we confirmed by qRT-PCR that the copy number of
integrant of clone No. 4 which is recovered in zeocin 100
µg/mL and 2000 µg/mL has a single copy integrant in the
genome (data not shown).
Since the transformation was conducted using a lin-
earized construct that favours single crossover recombina-
tion in the 5’ region of AOX1 locus, most of the transfor-
mants should be Mut+ (methanol utilization plus). Mut+
strain has wild-type ability to metabolize methanol as sole
carbon source. However, there is still a possibility that
recombination can also occur at the 3’ region of AOX1
locus, disrupting the wild-type AOX1 gene and creating
Muts (methanol utilization slow) transformants (Invitro-
gen 2010). IP cassette integration into the Pichia genome
was confirmed by PCR using specific primer pair for
AOX1 gene (AOX1F/AOX1R) (Figure 5). PCR of 18
colonies transformants resulted in two fragments of the
AOX1 gene (∼2000 bp) and IP cassette (∼500 bp). It re-
vealed that those 18 transformants are identified as Mut+.
Conversely, PCR of one colony transformant resulted in
only one fragment of an IP cassette (∼500 bp). It revealed
that one colony transformant is identified as Muts where
(a) (b)
FIGURE 3 Screening of P. pastoris X33 transformants in YPDS sup-
plementedwith zeocin (100 µg/mL) plate. (a) negative control (X33
without plasmid); (b) several clone transformants (X33 + linearized
pD902-PI) recovered in a zeocin plate.
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the recombination may have occurred through a double
crossover event. Sequencing analysis of the ∼500 bp am-
plicon of clone No. 4 was also conducted to confirm the
IP cassette integration into genome. The 511 bp amplicon
fragment has 100% identity to the sequence of pD902-IP
where it harbours the IP cassette (data not shown).
3.3. IP expression and protein analysis
The secretory expression of recombinant proteins in yeast
requires the presence of a signal sequence that helps the re-
combinant protein to enter the ER system, the initial step
for secretory expression. In P. pastoris, both full-length
S. cerevisiae α-factor signal sequence (89 amino acids)
and its truncated version have been successfully utilized
for secretory expression of recombinant proteins (Juturu
and Wu 2018). Protein secretion from the lumen of the
ER is occurred after folding and it frequently becomes the
rate-limiting step in the protein secretion. Therefore im-




FIGURE 4 Putative multicopy clones were cultured on YPD plates
with increasing zeocin concentrations: (a) 100; (b) 200; (c) 500; (d)
1000; (e) 1500; (f) 2000 µg/mL); NC = negative control (P. pastoris
X33wild-type strain). The clone transformants could be recovered
on zeocin concentration up to 2000 µg/mL.
ing peptide can enhance the secretion efficiency of the IP
(Kjeldsen et al. 2002).
Expression analysis of IP was done using one of the
Mut+ P. pastoris recombinant strains. The P. pastoris re-
combinant and wild-type strains were grown in BMMY
medium with 100% methanol added to a final concentra-
tion of 0.5% methanol every 24 h to maintain induction.
The supernatant was collected from the culture after 72
h of methanol induction. Secreted IP is predicted to con-
sist of 63 amino acids with a molecular weight of 7053
Da. Protein analysis of IP from culture supernatant was
conducted by SDS-PAGE using Tricine buffer system. It
shows that after 72 h induction, the culture supernatant
contained a protein with the size of above 6.5 kDa which
may represent the IP protein as it was not found in both the
culture supernatant of wild-type and 0 h methanol induc-
tion (Figure 6). The secreted IP comprised of 29 residues
of insulin B-chain and the 21 residues of insulin A-chain
connected by a short linker peptide DGK, has a smaller
FIGURE 5 Agarose electrophoresis of PCR confirmation of P. pas-
toris recombinant clones. M = Marker 1 kb plus DNA ladder; 1-19
= positive clones; P = control plasmid pD902-IP; G = control wild-
type; W = control negative (water). The methanol utilization phe-
notype of 19 clones tested was identified as Mut+ (18 clones = 1-
12,14-19) andMuts (1 clone = 13).
FIGURE 6 SDS-PAGE of recombinant human insulin precursor
in 10% SDS-PAGE gel. M = Polypeptide SDS-PAGE molecular
weight standards; Lane 1 = culture supernatant of wild-type post-
methanol induction (72 h); Lane 2 = expressed IP from P. pastoris re-
combinant clone 0 h post-methanol induction; Lane 3 = expressed
IP fromP. pastoris recombinant clone72hpost-methanol induction.
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size than the previous reported IP containing C-peptide
(34 amino acids) which has a molecular weight of 8 kDa
(Baeshen et al. 2016). The smaller IP which has short
connected linker (e.g. AAK or DGK) fused with suitable
prepro-leader promotes efficient secretion (Kjeldsen et al.
1999, 2012 Mar 6). In this study, the secreted IP con-
centration in small-scale expression was ∼30 mg/L after
72 h induction. After small-scale expression, the produc-
tion of IP can be scaled up in a shake flask or fermentor.
Large scale expression in the fermentor applying simple
fed-batch technique increases secretory expression of IP
in P. pastoris up to ∼3 g IP/L of culture broth as previ-
ously reported by Gurramkonda et al. (2009).
4. Conclusions
In conclusion, the truncated α-factor and a short C-peptide
(DGK) have successfully lead to the secretory expression
of IP in P. pastoris. In the future, we will further examine
the expression of IP in the fermentor scale for its subse-
quent purification and conversion to human insulin.
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